kyprolis - carfilzomib injection, powder, lyophilized, for solution
(Carfilzomib)Onyx Pharmaceuticals, Inc.
Usage: Kyprolis (carfilzomib) treats relapsed or refractory multiple myeloma in adults after one or more prior therapies. Used as a single agent or combined with lenalidomide, dexamethasone, daratumumab, isatuximab, or daratumumab/hyaluronidase-fihj plus dexamethasone.